Cortex – Life Sciences Insights

26 Jul, 2023

European Medicines Agency opens dialogue on use of AI in pharmaceutical life cycle

By Danny Tobey Keo Shaw Marco de Morpurgo

To open a dialogue with developers, academics, and regulators, the European Medicines Agency (EMA) recently published a draft Reflection...

17 Mar, 2023

By Keo Shaw Bethany Hills Daniel Tobey +1 more...

On March 1, 2023, FDA’s Center for Drug Evaluation and Research (CDER) published a discussion paper on artificial intelligence (AI) in...

23 Sep, 2022

By Coran Darling Keo Shaw Gareth Stokes

You wake up early to the sound of an alarm that only exists inside your own head, and it is silenced automatically as soon as you’re...

11 Jul, 2022

By Coran Darling

Use of AI in healthcare continues to solidify itself as a solid practice for the benefit of patients and healthcare providers. No more...

10 Jan, 2022

By Lyndsey Hudson

The launch of Nightingale Open Science last month – a new hub of medical data sets that could train AI (Artificial Intelligence) systems...

07 Oct, 2021

By Ellen Scordino Susan Krumplitsch

As part of our on-going podcast series - At the intersection of Science and Law, DLA Piper partners Ellen Scordino and Susan Krumplitsch...

05 Aug, 2021

By Nicholas Tyacke Alexandra de Zwart

Artificial Intelligence (AI) and machine learning are increasingly used in the life sciences industry for research and drug discovery,...

04 May, 2021

By James Clark Andrew Dyson Jan Pohle +1 more...

On 21 April 2021, the European Commission published the long-awaited proposal for a Regulation on Artificial Intelligence[1](“AI...

10 Jan, 2020

By Dr Kokularajah Paheenthararajah

The new German Digital Healthcare Act (Digitale‑Versorgung‑Gesetz/DVG), among many other groundbreaking changes, enables any physician or...

21 May, 2019

By Caroline Scott

Really looking forward to attending one of the biggest conferences in the life sciences sector in Scotland today - BioDundee. Some hot...